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Abstract The molecular mechanisms by which the
primordia of the midface grow and fuse to form the
primary palate are not well characterized. This is in
spite of the fact that failure of growth and/or fusion of
these facial primordia leads to the common human cra-
niofacial birth defects, clefts of the lip with or without
clefts of the palate. Members of the transforming growth
factor b (Tgfb) superfamily have been shown to play
critical roles during craniofacial development. Specifi-
cally, the role of Tgfb-3 in mediating the fusion of the
embryonic secondary palatal shelves is well document-
ed. In a screen for genes expressed during fusion of the
murine midfacial processes, Tgfb2 was identified as a
gene differentially expressed during fusion of the lateral
and medial nasal processes. The objective of our study
was to analyze the spatial and temporal expression of
Tgfb2 during critical stages of midfacial morphogenesis
at both the transcript and protein levels. We also com-
pared the pattern of expression of Tgfb2 with that of
Bmp4, a gene shown previously to be involved in me-
diating the fusion process in the midface. Our results
showed Tgfb2 expression in a very restrictive area of the
epithelial layer along the borders of the midfacial prim-
ordia, in a pattern very similar to that of Bmp4. The
highly restrictive and spatial and temporal pattern of
expression of Tgfb2 implicates its role in mediating the
fusion of the midfacial processes, possibly through in-
teracting with Bmp4 in the regulation of apoptosis and/
or epithelial–mesenchymal transformation. A greater
understanding of the role of this gene will clarify how
the normal midface grows and the mechanisms behind
cleft development.
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Introduction
Clefts of the lip and palate is the most common cra-
niofacial birth defect found in humans, with an inci-
dence as high as 1:500 in some racial populations
(Natsume et al., 1987). This birth defect occurs because
of defects in growth of the midfacial primordia during
early embryonic development.
Three midfacial prominences are visible during nor-
mal midfacial development: the medial and lateral nasal
prominences (MNP and LNP, respectively) medial and
lateral to the nasal pits and the maxillary primordium
(MP) of the first branchial arch. As these three facial
primordia reach the appropriate size, fusion of the
midfacial processes is initiated. The maxillary prim-
ordium, MP, first contacts the MNP, followed by fu-
sion of the LNP with the MNP (Trasler, 1968). The
MNP and LNP first contact at the posterior end of the
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nasal pits, where fusion between these two prominences
starts and proceeds anteriorly (Trasler, 1968). During
fusion, the epithelial layers of the facial processes con-
tact each other to form an epithelial seam, a bilayer
epithelium that increases in size and eventually disinte-
grates to allow penetration of the mesenchyme (Trasler,
1968; Wang et al., 1995). Failure of the growth and/or
fusion of the three facial primordia results in the for-
mation of the clefts of the lip with or without clefts of
the palate (Pelton et al., 1990).
The molecular mechanisms by which the primordia
of the midface grow and fuse to form the primary palate
are not well characterized. Transforming growth factor
b2 (Tgfb2) was one of the molecules identified in the
laboratory during a microarray screen of tissues of the
three midfacial processes taken before and after fusion.
Because of the well-documented evidence from the lit-
erature of the important roles of different members of
the Tgf family e.g. TGFb3 is critical for fusion of the
secondary palatal shelves (Proetzel et al., 1995; Kaar-
tinen et al., 1997), we performed spatial and temporal
analyses of the expression pattern of Tgfb2 during crit-
ical stages of growth and fusion of the three midfacial
processes. In addition, we also compared Tgfb2 expres-
sion pattern to that of another member of the Tgfb
superfamily, Bmp4, during midfacial fusion and found a
highly overlapping pattern of expression to the putative
site of fusion of the midfacial processes. We speculate
that Tgfb2 and Bmp4 play important roles in mediating
the fusion event of the primary palate.
Materials and methods
Mouse embryos
C57BL/6 male and female mice were obtained from Jackson Lab-
oratory (Bar Harbor, ME) and mated as described in Gong et al.
(2000). Embryos were removed at 10 and 11 days post-coitum (dpc)
and further substaged by tail somite count. Stages that represent the
different stages of fusion of the MNP and LNP were collected: tail
somite (TS) 4–6 (representing pre-fusion stage), TS 8–12 (fusion),
TS 13–16 (post-fusion), and primary palate enlargement (16–20).
Tissue preparation
Embryos were prepared for whole mount and section in situ hy-
bridization experiments according to Gong and Guo (2003) and for
immunohistochemistry according to Gong (2001). Embryos for
section in situ hybridization were embedded in OCT such that
cryosections of 10mm thickness in the transverse orientation were
obtained. For immunohistochemistry, paraffin-embedded embryos
were sectioned at 14 mm thickness were obtained in the transverse
and frontal orientation (refer to Fig. 2I for orientation of the
embryo).
In situ hybridization
Tgfb2 plasmids (50-Tgfb2 and 30-Tgfb2) were generated by
subcloning amplified fragments generated by polymerase chain



















Fragment length5 430 bp
Sequences of the two fragments generated from amplification of
the primers were specific to the Tgfb2 gene and share no homology
with other members of the Tgfb family as evidenced from DNA
database blasting. The fragments were inserted into EcoRI lineari-
zed and end-filled pGEMs-T Easy vector (Promega Corp.
Madison, WI) linear by blunt end ligation. The sequences of the
inserts were verified by sequencing. Both the 50-Tgfb2 and 30-Tgfb2
plasmids were linearized with ApaI and SacI restriction endonuc-
leases, and transcribed with Sp6 and T7 RNA polymerases in the
presence of digoxigenin nucleotides to generate sense and antisense
riboprobes, respectively.
The Bmp4 cDNA plasmid was a kind gift of Genetics Institutes
(Cambridge, MA).
Riboprobes generated from both the 50-Tgfb2 and 30-Tgfb2
plasmids were used in in situ hybridization on midfacial sections
and yielded identical expression pattern. All subsequent in situ hy-
bridization experiments were performed with the 5-Tgfb2 ribo-
probe. A temperature of 601C was used for hybridization with both
Tgfb2 and Bmp4 riboprobes.
Immunohistochemistry
Immunohistochemistry was performed according to Gong (2001).
Briefly, frontal and transverse sections of the midfacial region of
the different staged embryos were reacted with two antibodies. The
antibody against Tgfb2 was a polyclonal antibody generated with
synthetic peptide that corresponded to amino acids 50–75 of the
mature human Tgfb2 (Santa-Cruz Biotechnology, CA) (dilu-
tion5 1:500). The corresponding sequence in the mouse differed
only by two amino acids whose structures were closely related to
each other (Burt and Paton, 1992; Olaso et al., 1997). The antibody
against Bmp4 was a polyclonal antibody generated with a synthetic
peptide mapping at the amino terminus of the BMP-4 of human
origin and differs from the corresponding mouse sequence by
two amino acids (sc-6896, Santa-Cruz Biotechnology) (dilution—
1:150).
The Vectastain Elite ABC kit (Vector Laboratories, Burlingame,
CA) was used with biotinylated goat anti-rabbit IgG as the second
antibody. Negative controls were performed concurrently without
the presence of the primary antibody.
Results
Expression of Tgfb2 in the developing midface
Tgfb2 was one of the genes identified in an original mi-
croarray screen to search for genes that may play a critical
role in the growth and fusion of the midfacial region to
become the primary palate (Gong et al., 2005). Confir-
mation of the differential expression of this gene at two
stages (pre-fusion and fusion) of midfacial development
by reverse-transcriptase quantitative polymerase chain re-
action showed a small (less than twofold), but statistically
significant, up-regulation of the gene as the midfacial
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processes fuse (S.-G. Gong, T.-W. Gong, and L. Shum,
data not shown). We proceeded to map the spatial dis-
tribution of this gene during midfacial growth.
Before fusion of the midfacial processes, the expres-
sion of Tgfb2 was not observed at the transcript level
(Fig. 1A). Once the process of fusion is initiated, ex-
pression of the Tgfb2 gene became apparent at the pos-
terior ends of the MNP and LNP as they come into
contact with each other to initiate the process of fusion
(Fig. 1). Tgfb2 transcripts were tightly restricted to the
leading edges of the ‘‘zipper’’ formed by the posterior
ends of both the LNP and MNP (black arrows in Fig.
1B, C). At the cellular level, the expression of the gene
transcripts was clearly restricted to the ectodermal layer
of the MP and MNP (Fig. 2I, A–C) and the MNP and
LNP (Fig. 2I–D). The gene was also expressed in the
ectoderm of the LNP and MNP more anterior to the
fusion site (Fig. 2I–E), corresponding to the expression
observed in Fig. 1C. At the protein level, Tgfb2 was
observed in the epithelial seams of the contact of MP/
MNP (Fig. 2II–A, B) and LNP/MNP (Fig. 2II–C, D).
However, in contrast to its mRNA expression, Tgfb2
protein was present at very low levels or absent in the
epithelial layers of the LNP and MNP that were not in
contact (compare Fig. 2II–E with Fig. 2I–E). At a later
developmental stage, when the epithelial seam had bro-
ken down and there was mesenchymal bridge forma-
tion, remnants of the Tgfb2-expressing cells were only
found in the epithelial triangles found on the nasal and
oral part of the fusion site (arrows in Fig. 2II–F, H, J).
Expression of Bmp4 and Tgfb2 in the midface
The expression of Tgfb2 in the developing midfacial re-
gion was reminiscent of that of Bmp4 (Gong and Guo,
2003). We therefore conducted Bmp4 and Tgfb2 expres-
sion analyses at both the transcript and protein levels
with commercially available antibodies. Consecutive sec-
tions through the developing midfacial region were uti-
lized for the experiments for ease of comparison.
At the transcript levels, there appeared to be over-
lapping expression in the epithelial seam of the fusion
site between the two genes. Bmp4, however, had a
broader domain of expression, being present in ecto-
dermal layer of the MP (no expression of Tgfb-2 in
Fig. 3A compared with Bmp4 in Fig. 3B) and strong
expression in the medial aspect of the MNP (white ar-
row in Fig. 3F; Gong and Guo, 2003). By comparison,
Tgfb-2 mRNA expression was restricted to the layers of
epithelial seam (white arrow in Fig. 3E) and decreased
in amount anterior to the contact site (Fig. 3I). Bmp4
transcripts persisted more anteriorly in the LNP and
MNP i.e. more rostrally upwards the tips of the LNP
and MNP (compare Fig. 3I and J). Both proteins were
found to be expressed at the site of fusion of the LNP
and MNP, specifically in and around the epithelial seam
of the fusion site. One major difference, however, was
the broader distribution of Bmp4 in the epithelial seam
cells and some mesenchymal cells around the seam (Fig.
4A, arrow in a). Tgfb2 protein, however, was restricted
to cells in the epithelial seam (Fig. 4B, arrow in b) and
never observed in any mesenchymal cells around the site
of fusion.
Discussion
Our original microarray screen was initiated as an at-
tempt to identify molecules that are involved in growth
and fusion of the palate (Gong et al., 2005). The spatial
expression of this gene, as presented in this paper,
showed a pattern that suggested that Tgfb2 may play an
important role during midfacial morphogenesis, specif-
ically in mediating fusion of the MP with the MNP
and the fusion of the MNP with the LNP.
The expression of Tgfb2 in the primary palate is
reminiscent of the expression pattern of Tgfb3 in the
developing secondary palate. Both Tgfb2 and Tgfb3
belong to the large Tgfb family, all of which regulate a
broad spectrum of biological responses on a large va-
riety of cell types (e.g. Rizzino, 1988; Pelton et al., 1991;
McCartney-Francis and Wahl, 1994). Tgfb3 is ex-
pressed at relatively high levels in the leading borders
of the palatal shelves (known as the medial edge epi-
thelium, MEE) (Ferguson, 1988) before fusion of the
palatal shelves and disappears soon after fusion of the
shelves, very similar to what we observed with Tgfb2
expression in the primary palate. Following the first
expression mapping of the Tgfb3 gene to the MEE,
numerous studies have shown a critical role for Tgfb3 in
the fusion event of the secondary palate. Not only does
Fig. 1. Transforming growth factor b-2 (Tgfb)-2 mRNA expression.
Frontal views of whole embryos at (A) pre-fusion (B) early fusion,
(C) mid-fusion, and (D) late fusion stages of midfacial development
and hybridized with Tgfb2 riboprobe. Tgfb2 expression was present
at the leading edges of the lateral and medial nasal prominences
(LNP and MNP) (black arrows in B and C) before fusion. Ex-
pression of the gene was also obvious at the fusion site of the MNP
with the MP. There was no visible expression of the gene before
fusion (A) or after fusion had occurred (D).
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Tgfb3-null mutation result in 100% penetrance of cleft
secondary palate (Kaartinen et al., 1995; Proetzel et al.,
1995), various studies have clearly shown that clefts of
the secondary palate are because of failure of the fusion
event. For example, blockade of Tgfb3 in vitro prevents
palatal fusion and this blockade can be rescued by ad-
dition of Tgfb3 to the culture medium (Brunet et al.,
1995; Kaartinen et al., 1997; Taya et al., 1999).
In light of the similarity in the pattern of expression
of Tgfb3 and Tgfb2 during secondary and primary
palatogenesis, respectively, and the known role of Tgfb3
in mediating fusion of the secondary palate, it is pos-
Fig. 2 Midfacial expression of transforming growth factor b-2
(Tgfb-2) mRNA and protein. (I) Transverse sections through the
midface of a tail somite (TS) 12 embryo hybridized with Tgfb2
riboprobe. The sections were from a posterior to anterior direction
of the same embryo during the fusion stage. TGFb-2 was restricted
to the epithelia of the site of fusion of the medial nasal prominences
(MNP) with the MP (A–C), and in the epithelia of the leading
edges of the lateral nasal prominences (LNP) and MNP (D, E). (II)
Immunohistochemistry with antibody against TGFb2 on trans-
verse (A–F) and frontal (G–H) sections through the midface of TS9
(A–B), TS12 (C–E), TS16 (F–H), TS 24 (I–J). (I) and (J) were
counterstained with 1% hematoxylin. TGFb2 protein was present
in the bilayer epithelia of fusion of the MNP with MP (A) and at
the site of fusion of the LNP and MNP (C, D). The protein was
absent where there was no contact between the epithelial layers. In
older embryo, the protein was found in detectable levels in the
olfactory epithelium of the medial wall of the nasal cavity (G).
During the disintegration of the epithelial seam, remnants of the
protein were present in the epithelial triangles on the nasal and oral
sides (arrows in F, H, and J). Transverse and horizontal sections
were prepared as in the horizontal lines in the diagram of an em-
bryo at infero-frontal view.
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sible that Tgfb2 is involved in mediating fusion of the
primary palate. At the structural level, Tgf-b 2 and 3 are
very similar: each is synthesized as a prepro monomeric
polypeptide cleaved at a multibasic peptide sequence to
yield a 112–114 amino acid molecule (Miller et al.,
1990). Mature TGF-b2 protein has approximately 80%
identity to TGF-b3 (Derynck et al., 1988; ten Dijke
et al., 1988). However, several differences are worth
noting. Although Tgfb2 and Tgfb3 show high similarity
at the structural level, the N-terminal regions of these
two molecules show only 27% sequence identity to each
other. In addition, although Tgfb2-null mice exhibit
developmental defects in several systems, clefts of the lip
have not been reported in these mice (Sanford et al.,
1997). Interestingly, the Tgfb2 loss-of-function muta-
tion does result in cleft palate; the penetrance, however,
is only 23% (Sanford et al., 1997) and could result from
its expression in the cranial neural crest derived mesen-
chyme beneath the MEE. Tgfb2 is restricted during
secondary palatogenesis to the mesenchyme (Fitzpa-
trick et al., 1990; Pelton et al., 1990); clefts of the sec-
ondary palate in these null mutants are likely the result
of an interference in the mesenchymal growth compo-
nent of the developing secondary palatal shelves.
Tgf b3 is believed to play a role in enhancing the
transformation of MEE cells into the palatal mesen-
chyme and inducing apoptosis in the MEE (Sun et al.,
1998; Martinez-Alvarez et al., 2000; Ito et al., 2001,
2003; Cuervo et al., 2002; Cuervo and Covarrubias,
2004). The primary palate is also believed to undergo
these two biological events during fusion (Sun et al.,
2000). In the primary palate, however, we speculate that
during fusion of the midfacial processes, Tgfb2 may
work together with Bmp4, another member of the Tgfb
superfamily. The similarity of expression pattern in the
epithelial layers of the site of fusion lends strong sup-
port to the possibility that both Bmp4 and Tgfb2 have
roles in mediating apoptosis and/or EMT at the fusion
site of the midface. Although there is overlapping ex-
pression pattern with Tgfb2 in the leading edges of the
fusion site of the MP/MNP and MNP/LNP, Bmp4
expression covers a more extensive area, being present
in the MP and further rostrally in the leading edges of
the epithelium of fusion. Another distinct difference is
that as fusion occurs, Tgfb2 expression was lost and
restricted to the oral and nasal triangles of the epithelial
fusion site. In fact, Tgfb2 protein was never observed in
epithelial cells of the midfacial processes that were not
in contact with each other and appeared to be more
restricted to the superficial layer of the epithelia of facial
processes. Bmp4 expression, on the other hand, was
observed in the epithelial seam as it breaks down to
allow mesenchymal confluence, followed by a shift to
the mesenchyme as its epithelial expression in the fusion
site disappears completely (Gong and Guo, 2003). In
addition, Bmp4 protein was observed not only in the
epithelial seam but also in the immediate surrounding
mesenchymal cells, suggesting a paracrine mode of ac-
tion of the protein in the developing midfacial process-
es. The complementary, yet distinct, pattern of Tgfb2
and Bmp4 expression suggests a possible interactive role
of these two molecules in mediating the fusion event in
the primary palate. It is possible that one molecule,
possibly Tgfb2, could be involved in mediating apop-
tosis, while the other, Bmp4 possibly, in mediating EMT
of the epithelial cells during fusion. Another possibility
is that these two molecules, and perhaps others, work
Fig. 3 Comparison of expression of midfacial expression of
(Tgfb-2) and Bmp4 transcripts. (A) Transverse sections (from pos-
terior to anterior direction of embryo during fusion stage tail
somite (TS)5 12. TGFb-2 is restricted to the growing edges of the
lateral and medial nasal prominences (LNP and MNP) in the
epithelial layers. (B) Sections showing Bmp4 expression, in the same
orientation and stage of development in that of the Tgfb-2 sections.
However, Bmp4 has a wider domain of expression, and appears
earlier in a more posterior section, featured on the maxillary proc-
ess in addition to the MNP and LNP.
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together to ‘‘share’’ the job of mediating fusion at dif-
ferent stages of development.
One potential mechanism for ‘‘sharing’’ functions
during fusion of the primary palate could be the inter-
play and the convergence of the signaling pathways
used by these two members of the Tgfb superfamily. All
members of the Tgf-b superfamily mediate their bio-
logical responses through a receptor signaling complex,
consisting of a ligand binding Tgf-b receptor type II
(TbR-II), and a Tgf-b receptor type I (activin receptor-
like kinase, Alks) (Heldin et al., 1997; Shi and Mass-
ague, 2003; Waite and Eng, 2003). Upon ligand bind-
ing, type II receptors associate with and phosphorylate
type I receptors which then bind and phosphorylate the
intracellular signaling mediators, Smads (Heldin et al.,
1997; Shi and Massague, 2003; Waite and Eng, 2003).
Smad1, Smad5, and Smad8 mediate the Bmps signaling
through Alk-3 and Alk-6, whereas Smad2 and Smad3
mediate the TGF-bs and activin signaling through Alk-
5 (Heldin et al., 1997; Shi and Massague, 2003; Waite
and Eng, 2003). Several lines of evidence suggest that
the biological responses initiated by Tgfb3 during sec-
ondary palatogenesis are mediated by this particular
pathway. For example, embryonic secondary palatal
tissue contains functional types I and II Tgfb receptors
(Linask et al., 1991; Cui and Shuler, 2000) that when
activated, elicit changes such as cell proliferation (Lin-
ask et al., 1991) and the synthesis of extracellular matrix
components (D’Angelo and Greene, 1991; D’Angelo
et al., 1994); the involvement of specific Smad proteins
such as Smad2 in Tgfb-initiated signaling in cells of the
embryonic palate (Greene et al., 2003); and the Alk-5/
Smad pathway mediates Tgfb3 induced palatal fusion
(Dudas et al., 2004). During primary palate develop-
ment, it is conceivable that there is more than one mol-
ecule that mediates fusion, and that should one
molecule be absent or non-functional, the others step
up to the plate. The speculation of there being more
than one player involved in mediating fusion in the
primary palate is supported by an interesting observa-
tion with null mutant mice: of the numerous phenotypes
generated from knock-out mice, very few have clefts of
the lip. Functional studies of various kinds will need to
be performed to test out the hypothesis of several play-
ers mediating fusion of the primary palate.
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